Executive Director, US Access Strategy

The Executive Director of US Market Access Strategy will lead the integrated market access strategy for BMS’s Oncology portfolio, overseeing US market access strategy development and execution.

Requirements

• Develop end-to-end US access strategy for BMS’ full Oncology and hematology in-line and pipeline portfolio
• Critical to understand pipeline and be able to transition global launch strategy work quickly to US post CSRE
• Represent US on the committees for access related decisions eg DEX, CRF, Price exception
• Work with and leverage the expertise of their team and functional partners to develop strategy for topics like brand pricing, launch sequencing, payer / provider contracting, payer marketing, PASS, and GTN management
• Provide US access strategy support throughout the lifecycle of each asset (i.e., from pre-launch to LOE)
• Develop portfolio-wide standard for launch strategy. Establish objectives and metrics for access success. Measure progress towards agreed upon market access and launch objectives
• Assess forward-looking trends in the marketplace, working with internal BMS stakeholders to develop innovative approaches to address any external challenges
• Build and lead a high performing team by attracting, developing, and retaining individuals through effective coaching and feedback
• Develop and maintain up-to-date knowledge for training of new and existing team members
• Develop market access programing to upskill team members as business priorities change
• Cultivate a culture of continuous learning and innovation by empowering teams with internal rotations both within Market Access and the broader organization

Benefits

• Health Coverage
• Wellbeing Support
• Financial Well-being and Protection
• Work-life benefits